Ceftaroline in combination with trimethoprim-sulfamethoxazole for salvage therapy of methicillin-resistant staphylococcus aureus bacteremia and endocarditis

Valeria Fabre, Marcela Ferrada, Whitney R. Buckel, Edina Avdic, Sara E. Cosgrove

Research output: Contribution to journalArticlepeer-review

Abstract

No clinical trials have investigated the use of ceftaroline fosamil for salvage therapy of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis. We report data on 29 patients who received ceftaroline ± another antimicrobial for this indication. Ninety percent of patients had microbiologic cure and 31% had treatment success with a median follow-up of 6 months.

Original languageEnglish (US)
JournalOpen Forum Infectious Diseases
Volume1
Issue number2
DOIs
StatePublished - Sep 1 2014

Keywords

  • Bacteremia
  • Ceftaroline fosamil
  • MRSA
  • Salvage

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Ceftaroline in combination with trimethoprim-sulfamethoxazole for salvage therapy of methicillin-resistant staphylococcus aureus bacteremia and endocarditis'. Together they form a unique fingerprint.

Cite this